A new biotech company is moving to San Francisco’s Mission Bay, which has been marked as The City’s innovation hub.
Mayor Gavin Newsom today announced that Bayer HealthCare’s pharmaceutical division is establishing its U.S. Innovation Center, bundling its U.S. research activities and expanding its global research network in Mission Bay.
“I’m proud of The City’s work to bring Bayer’s innovative, entrepreneurial spirit to San Francisco,” Newsom said. “We expect the U.S. Innovation Center to further catalyze and anchor the significant activity and growth we’ve already seen at Mission Bay, cementing its place as the premier biotech cluster in the nation.”
Bayer’s U.S. Innovation Center’s features a U.S. Science Hub, a dedicated team of 65 scientists and researchers who will work to build partnerships and collaborations ranging from the research bench to the clinic, according to the Mayor’s Office. The U.S. Innovation Center also will house Bayer scientists who drive the company’s hematology research program focused on coagulation factors and the discovery of novel biologic drug candidates.
Bayer will occupy approximately 49,000 square feet of leased lab and administrative space and is scheduled to relocate its research team from its current space in Richmond in the fourth quarter of 2010.